News

Article

Pharmaceutical Technology

Pharmaceutical Technology, APIs, Excipients, and Manufacturing, October 2021
Volume
Pages: 18-21

Global Regulatory Approach to API Manufacturing

Author(s):

Meg Rivers

Navigating a complex global regulatory landscape involves upfront research into the expectations of the different regulatory bodies, thorough documentation of every step of the API manufacturing process, and good communication.

AdobeStock_293317053_magele-picture

AdobeStock_293317053_magele-picture

Prior to the commercialization phase for API manufacturing, there is a lot to juggle as well as a tricky global regulatory landscape to navigate. API manufacturers must meet the standards for the country where the drug will be distributed, and every country has its own regulations as well as its own interpretation of those regulations.

October 2021 API eBook

Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.

About the author

Meg Rivers is a senior editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

Article Details

Pharmaceutical Technology
eBook: October 2021
Pages: 18-21

Citation

When referring to this article, please cite it as M. Rivers, “Global Regulatory Approach to API Manufacturing," Pharmaceutical Technology eBook (October 2021).

Articles in this issue
Knowledge Management
Pharmaceutical Knowledge Management: Experiences in Drug Development and Manufacturing
Shining a Light on Photochemistry in Flow
Shining a Light on Photochemistry in Flow
Predicting Tablet Potency in Continuous Manufacturing
Predicting Tablet Potency in Continuous Manufacturing
Powder Testing
Building Robust Specifications Using Powder Testing
Global Regulatory Approach to API Manufacturing
Global Regulatory Approach to API Manufacturing
Seeking Economies of Scale for Biocatalysis
Seeking Economies of Scale for Biocatalysis
API Development and Manufacturing: Advantages of Working with Small Molecules
API Development and Manufacturing: Advantages of Working with Small Molecules
Rethinking, Recalibrating, and Retooling

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
medicine factory scientist worker work in Laboratory Plants Process. medical doctor working research in pharmaceutical industry. | Image Credit: ©Quality Stock Arts – stock.adobe.com
July 25th 2025

Interfering with Interventions in Aseptic Processing

James Agalloco
Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than limiting operator activities. Equipment, automation, procedural and component changes can be utilized to make the aseptic activities safer. This article offers suggestions for reducing the adverse impact of intervention throughout the aseptic process.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
June 25th 2024

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
Sand running through the bulbs of an hourglass | Image Credit: © BillionPhotos.com - stock.adobe.com
July 24th 2025

Customizable Relationships Enhance Speed to Market

Patrick Lavery
While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
May 28th 2024

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
July 23rd 2025

ICH Q12 and Post-Approval Changes–Less than Satisfactory State of Affairs

Siegfried Schmitt
Speedier implementation of the Post-Approval Change Management Protocol is essential for it to have a positive effect on supply security, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.
Magnifier with pills on blue background | Image Credit: © Pixel-Shot - stock.adobe.com
July 23rd 2025

Overcoming PK/PD Modeling Challenges

Cynthia A. Challener
Artificial intelligence and machine learning can help identify complex patterns.